Sarepta Therapeutics, Inc. SRPT Business Segments — Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — selling general and administrative expense of $40.19M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense decreased by 21.4% year-over-year, from $51.14M to $40.19M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense has grown at a 18.4% compound annual growth rate (CAGR), from $124.95M to $207.19M.
- What does business segments — selling general and administrative expense mean?
- Represents the operating expenses incurred for the administration, marketing, and sales support of the segment. It is a key metric for evaluating the segment's operational overhead and commercialization efficiency.